您好,欢迎访问黑龙江省农业科学院 机构知识库!

Preparation and Encapsulation of DPP-IV Inhibitory Peptides: Challenges and Strategies for Functional Food Development

文献类型: 外文期刊

作者: Zhao, Rui 1 ; Zhou, Ye 1 ; Shen, Huifang 1 ; Guan, Lijun 1 ; Wang, Yao 1 ; Shen, Xinting 1 ; Wang, Fei 1 ; Yao, Xinmiao 1 ;

作者机构: 1.Heilongjiang Acad Agr Sci, Food Proc Res Inst, Harbin 150086, Peoples R China

2.Heilongjiang Prov Key Lab Food Proc, Harbin 150086, Peoples R China

3.Heilongjiang Prov Engn Res Ctr Whole Grain Nutriti, Harbin 150086, Peoples R China

关键词: DPP-IV inhibitory peptide; bioinformatics; enzymatic hydrolysis; fermentation; encapsulation

期刊名称:FOODS ( 影响因子:5.1; 五年影响因子:5.6 )

ISSN:

年卷期: 2025 年 14 卷 9 期

页码:

收录情况: SCI

摘要: Dipeptidyl peptidase IV (DPP-IV) inhibitory peptides have emerged as promising functional ingredients for managing type 2 diabetes due to their ability to enhance insulin secretion and improve glycemic control. This review provides a concise overview of current strategies for the preparation and encapsulation of DPP-IV inhibitory peptides, with a focus on food industry application, evaluating bioinformatics for substrate selection, and methods like mild enzymatic hydrolysis, cost-effective fermentation, and high-purity chemical synthesis for peptide production. Challenges associated with incorporating these peptides into food products are addressed, including impacts on sensory properties, stability during processing and digestion, and the need for effective delivery systems to enhance bioavailability. Potential solutions to improve peptide stability and targeted release, such as emulsions, liposomes, and nanoparticles, are explored. Future research directions are outlined, emphasizing the necessity for scalable production methods, co-encapsulation strategies, and consumer acceptance studies to facilitate the commercialization of DPP-IV inhibitory peptides as functional food ingredients. By addressing these key areas, this review aims to provide a theoretical foundation and practical guidance for the development of DPP-IV inhibitory peptides, paving the way for their broader application in the prevention and management of type 2 diabetes.

  • 相关文献
作者其他论文 更多>>